Your browser doesn't support javascript.
loading
Immunological biomarkers predict HIV-1 viral rebound after treatment interruption.
Hurst, Jacob; Hoffmann, Matthias; Pace, Matthew; Williams, James P; Thornhill, John; Hamlyn, Elizabeth; Meyerowitz, Jodi; Willberg, Chris; Koelsch, Kersten K; Robinson, Nicola; Brown, Helen; Fisher, Martin; Kinloch, Sabine; Cooper, David A; Schechter, Mauro; Tambussi, Giuseppe; Fidler, Sarah; Babiker, Abdel; Weber, Jonathan; Kelleher, Anthony D; Phillips, Rodney E; Frater, John.
Afiliación
  • Hurst J; Nuffield Department of Clinical Medicine, Peter Medawar Building for Pathogen Research, John Radcliffe Hospital, Oxford OX1 3SY, UK.
  • Hoffmann M; Institute for Emerging Infections, The Oxford Martin School, Oxford OX1 3BD, UK.
  • Pace M; Nuffield Department of Clinical Medicine, Peter Medawar Building for Pathogen Research, John Radcliffe Hospital, Oxford OX1 3SY, UK.
  • Williams JP; Nuffield Department of Clinical Medicine, Peter Medawar Building for Pathogen Research, John Radcliffe Hospital, Oxford OX1 3SY, UK.
  • Thornhill J; Institute for Emerging Infections, The Oxford Martin School, Oxford OX1 3BD, UK.
  • Hamlyn E; Nuffield Department of Clinical Medicine, Peter Medawar Building for Pathogen Research, John Radcliffe Hospital, Oxford OX1 3SY, UK.
  • Meyerowitz J; Division of Medicine, Wright Fleming Institute, Imperial College, London W2 1PG, UK.
  • Willberg C; Caldecot Centre, King's College Hospital NHS Foundation Trust, London SE5 9RS, UK.
  • Koelsch KK; Nuffield Department of Clinical Medicine, Peter Medawar Building for Pathogen Research, John Radcliffe Hospital, Oxford OX1 3SY, UK.
  • Robinson N; Nuffield Department of Clinical Medicine, Peter Medawar Building for Pathogen Research, John Radcliffe Hospital, Oxford OX1 3SY, UK.
  • Brown H; Oxford National Institute of Health Research Biomedical Research Centre, Oxford OX3 7LE, UK.
  • Fisher M; St Vincent's Centre for Applied Medical Research and The Kirby Institute, UNSW Australia, Sydney, New South Wales 2052, Australia.
  • Kinloch S; Nuffield Department of Clinical Medicine, Peter Medawar Building for Pathogen Research, John Radcliffe Hospital, Oxford OX1 3SY, UK.
  • Cooper DA; Institute for Emerging Infections, The Oxford Martin School, Oxford OX1 3BD, UK.
  • Schechter M; Oxford National Institute of Health Research Biomedical Research Centre, Oxford OX3 7LE, UK.
  • Tambussi G; Nuffield Department of Clinical Medicine, Peter Medawar Building for Pathogen Research, John Radcliffe Hospital, Oxford OX1 3SY, UK.
  • Fidler S; Institute for Emerging Infections, The Oxford Martin School, Oxford OX1 3BD, UK.
  • Babiker A; Oxford National Institute of Health Research Biomedical Research Centre, Oxford OX3 7LE, UK.
  • Weber J; Department of HIV and Sexual Health, Brighton and Sussex University Hospitals, Brighton BN2 5BE, UK.
  • Kelleher AD; Division of Infection and Immunity, University College London, London WC1E 6BT, UK.
  • Phillips RE; St Vincent's Centre for Applied Medical Research and The Kirby Institute, UNSW Australia, Sydney, New South Wales 2052, Australia.
  • Frater J; Projeto Praça Onze, Hospital Escola São Francisco de Assis, Universidade Federal do Rio de Janeiro, Rio de Janeiro RJ 21941-901, Brazil.
Nat Commun ; 6: 8495, 2015 Oct 09.
Article en En | MEDLINE | ID: mdl-26449164
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Biomarcadores / Infecciones por VIH / VIH-1 / Fármacos Anti-VIH Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2015 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Biomarcadores / Infecciones por VIH / VIH-1 / Fármacos Anti-VIH Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2015 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido